Nanoveu (ASX:NVU) Expands Listed Shares Following ASX Quotation Application

Highlights

• Nanoveu has applied to quote 3 million new ordinary shares on the Australian Securities Exchange.
• The additional shares form part of a previously announced capital management transaction.
• The quotation expands the company's listed securities and supports future corporate flexibility.

Nanoveu Ltd (ASX:NVU), an emerging technology company focused on advanced software and artificial intelligence solutions, has announced an application to quote 3 million new ordinary fully paid shares on the Australian Securities Exchange. The quotation forms part of an earlier disclosed securities issue under the ASX Listing Rules and reflects the company's ongoing capital management activities. As a technology-focused company listed on the All Ordinaries , Nanoveu continues strengthening its capital structure while pursuing future growth initiatives. The latest announcement also places attention on ASX Technology Stocks as smaller technology companies continue advancing strategic development plans.

Nanoveu applies to quote additional shares

Nanoveu has lodged an Appendix 2A application with the Australian Securities Exchange seeking quotation of 3 million ordinary fully paid shares.

The new securities are scheduled to commence quotation from early July and relate to a transaction previously disclosed through an Appendix 3B announcement.

The quotation increases the number of listed ordinary shares available for trading on the market.

Capital management remains a strategic focus

The latest quotation forms part of Nanoveu's broader capital management strategy.

Companies frequently issue additional securities to support various corporate objectives, including:

• Strategic growth initiatives
• Business expansion
• Corporate transactions
• Capital management
• Financial flexibility

The latest application reflects an administrative step following an earlier approved securities issue.

Listed securities continue expanding

The quotation increases Nanoveu's issued ordinary shares available on the ASX.

An expanded share base may contribute to:

• Improved market liquidity
• Greater trading flexibility
• Broader shareholder participation
• Enhanced market accessibility
• Ongoing corporate funding flexibility

The company has not announced any change to its underlying business operations alongside the quotation.

Technology sector continues evolving

Australia's technology sector continues attracting attention as businesses develop solutions across artificial intelligence, software and digital innovation.

Several long-term trends continue supporting sector development:

Artificial intelligence

Businesses continue integrating AI-powered solutions across multiple industries.

Digital transformation

Organisations continue investing in technology-driven productivity improvements.

Enterprise software

Software adoption remains an important driver of operational efficiency.

Innovation

Technology companies continue developing new commercial applications.

These structural themes continue supporting Australia's growing technology sector.

Financial flexibility remains important

Capital management plays an important role for emerging technology companies.

Maintaining financial flexibility allows businesses to:

• Pursue commercial opportunities
• Support product development
• Evaluate strategic partnerships
• Strengthen operational capacity
• Respond to changing market conditions

Additional listed securities may provide greater flexibility as companies continue executing long-term business strategies.

ASX quotation follows regulatory process

Applications to quote additional securities are completed under the ASX Listing Rules.

The Appendix 2A process confirms that securities previously approved for issue are eligible to begin trading on the exchange.

This process supports transparency and ensures compliance with ASX regulatory requirements.

Market attention remains on execution

While the quotation increases the company's listed securities, longer-term market attention is expected to remain focused on operational execution.

Future developments likely to attract attention include:

• Commercial progress
• Product development
• Strategic partnerships
• Revenue growth
• Technology innovation

These operational milestones will continue providing greater insight into the company's long-term direction.

Nanoveu continues progressing its capital management strategy through the quotation of additional ordinary shares on the Australian Securities Exchange. While the latest announcement primarily relates to listed securities administration, maintaining financial flexibility remains important as the company continues developing its technology portfolio. Future attention is expected to remain centred on commercial execution, innovation and broader business growth.